circ-MALAT1 is significantly higher in HCC cancer stem-like cells than in adherent HCC cells based on quantitative RT-qPCR. The text links circ-MALAT1 to CSC self-renewal through PAX5/TP53 inhibition and JAK2/STAT3 activation.
Circular RNA MALAT1 as a potential target for antimetastatic therapy.